These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 15573021)

  • 41. Acetaldehyde stimulates the activation of latent transforming growth factor-beta1 and induces expression of the type II receptor of the cytokine in rat cultured hepatic stellate cells.
    Chen A
    Biochem J; 2002 Dec; 368(Pt 3):683-93. PubMed ID: 12223100
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The stress system in the human brain in depression and neurodegeneration.
    Swaab DF; Bao AM; Lucassen PJ
    Ageing Res Rev; 2005 May; 4(2):141-94. PubMed ID: 15996533
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of chronic oestrogen replacement on stress-induced activation of hypothalamic-pituitary-adrenal axis control pathways.
    Dayas CV; Xu Y; Buller KM; Day TA
    J Neuroendocrinol; 2000 Aug; 12(8):784-94. PubMed ID: 10929091
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Transforming growth factor-β1 up-regulates connexin43 expression in human granulosa cells.
    Chen YC; Chang HM; Cheng JC; Tsai HD; Wu CH; Leung PC
    Hum Reprod; 2015 Sep; 30(9):2190-201. PubMed ID: 26202915
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Sex hormone-induced mammary carcinogenesis in female Noble rats: expression of TGF-beta1 and its receptors, TGF-alpha, and EGF-R in mammary carcinogenesis.
    Xie B; Tsao SW; Wong YC
    Breast Cancer Res Treat; 1999 Dec; 58(3):227-39. PubMed ID: 10718485
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Latent transforming growth factor-beta activation in mammary gland: regulation by ovarian hormones affects ductal and alveolar proliferation.
    Ewan KB; Shyamala G; Ravani SA; Tang Y; Akhurst R; Wakefield L; Barcellos-Hoff MH
    Am J Pathol; 2002 Jun; 160(6):2081-93. PubMed ID: 12057913
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Defective processing of the transforming growth factor-beta1 in azoxymethane-induced mouse colon tumors.
    Guda K; Claffey KP; Dong M; Nambiar PR; Rosenberg DW
    Mol Carcinog; 2003 May; 37(1):51-9. PubMed ID: 12720300
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Potential mechanisms for the plasmin-mediated release and activation of latent transforming growth factor-beta1 from the extracellular matrix of growth plate chondrocytes.
    Pedrozo HA; Schwartz Z; Robinson M; Gomes R; Dean DD; Bonewald LF; Boyan BD
    Endocrinology; 1999 Dec; 140(12):5806-16. PubMed ID: 10579347
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Regulation of transforming growth factor beta1 by nitric oxide.
    Vodovotz Y; Chesler L; Chong H; Kim SJ; Simpson JT; DeGraff W; Cox GW; Roberts AB; Wink DA; Barcellos-Hoff MH
    Cancer Res; 1999 May; 59(9):2142-9. PubMed ID: 10232601
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of transforming growth factor (TGF)-beta Type I and TGF-beta type II receptors in the TGF-beta1-regulated gene expression in pituitary prolactin-secreting lactotropes.
    Sarkar DK; Pastorcic M; De A; Engel M; Moses H; Ghasemzadeh MB
    Endocrinology; 1998 Aug; 139(8):3620-8. PubMed ID: 9681516
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Induction of porcine-specific regulatory T cells with high specificity and expression of IL-10 and TGF-β1 using baboon-derived tolerogenic dendritic cells.
    Li M; Eckl J; Abicht JM; Mayr T; Reichart B; Schendel DJ; Pohla H
    Xenotransplantation; 2018 Jan; 25(1):. PubMed ID: 29057512
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Structural basis of latent TGF-β1 presentation and activation by GARP on human regulatory T cells.
    Liénart S; Merceron R; Vanderaa C; Lambert F; Colau D; Stockis J; van der Woning B; De Haard H; Saunders M; Coulie PG; Savvides SN; Lucas S
    Science; 2018 Nov; 362(6417):952-956. PubMed ID: 30361387
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Overexpression of human transforming growth factor-beta1 using a recombinant CHO cell expression system.
    Zou Z; Sun PD
    Protein Expr Purif; 2004 Oct; 37(2):265-72. PubMed ID: 15358346
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Transforming growth factor beta-1 influence on fetal allografts during pregnancy.
    Ayatollahi M; Geramizadeh B; Samsami A
    Transplant Proc; 2005 Dec; 37(10):4603-4. PubMed ID: 16387180
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transforming growth factor-beta1 and renal cell cancer: cell growth, mRNA expression and protein production of cytokines.
    Shimabukuro T; Ohmoto Y; Naito K
    J Urol; 2003 May; 169(5):1865-9. PubMed ID: 12686863
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Insulin-like growth factor-II/mannose 6 phosphate receptors facilitate the matrix effects of latent transforming growth factor-beta1 released from genetically modified keratinocytes in a fibroblast/keratinocyte co-culture system.
    Ghahary A; Tredget EE; Shen Q
    J Cell Physiol; 1999 Jul; 180(1):61-70. PubMed ID: 10362018
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The first stage of transforming growth factor beta1 activation is release of the large latent complex from the extracellular matrix of growth plate chondrocytes by matrix vesicle stromelysin-1 (MMP-3).
    Maeda S; Dean DD; Gomez R; Schwartz Z; Boyan BD
    Calcif Tissue Int; 2002 Jan; 70(1):54-65. PubMed ID: 11907708
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Associated changes of lipid peroxidation and transforming growth factor beta1 levels in human colon cancer during tumour progression.
    Biasi F; Tessitore L; Zanetti D; Cutrin JC; Zingaro B; Chiarpotto E; Zarkovic N; Serviddio G; Poli G
    Gut; 2002 Mar; 50(3):361-7. PubMed ID: 11839715
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transforming growth factors beta1, beta2 and beta3 and their receptors are differentially expressed in human peritoneal fibroblasts in response to hypoxia.
    Saed GM; Collins KL; Diamond MP
    Am J Reprod Immunol; 2002 Dec; 48(6):387-93. PubMed ID: 12607775
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In vitro treatment of human transforming growth factor-beta1-treated monocyte-derived dendritic cells with haptens can induce the phenotypic and functional changes similar to epidermal Langerhans cells in the initiation phase of allergic contact sensitivity reaction.
    Aiba S; Manome H; Yoshino Y; Tagami H
    Immunology; 2000 Sep; 101(1):68-75. PubMed ID: 11012755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.